15 min listen
ACR2021 - Day4e
FromRheumnow Podcast
ratings:
Length:
48 minutes
Released:
Nov 9, 2021
Format:
Podcast episode
Description
Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope
Best of PsA Day 4 (Tuesday): MACE in PsA: Dr. Rachel Tate
Predicting Progression from Psoriasis to PsA: Dr. Robert Chao
David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk.
Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof
Can We Stop Medication in Systemic JIA? Dr. Bella Mehta
Day 4 SpA Highlights - Pregnancy in SpA and Drug Monitoring: Dr. Robert Chao
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope
Best of PsA Day 4 (Tuesday): MACE in PsA: Dr. Rachel Tate
Predicting Progression from Psoriasis to PsA: Dr. Robert Chao
David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk.
Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof
Can We Stop Medication in Systemic JIA? Dr. Bella Mehta
Day 4 SpA Highlights - Pregnancy in SpA and Drug Monitoring: Dr. Robert Chao
Released:
Nov 9, 2021
Format:
Podcast episode
Titles in the series (100)
The RheumNow Week In Review 24 March 2017: The RheumNow Week In Review 24 March 2017 by Dr. Cush by Rheumnow Podcast